Invasive Aspergillosis
📧 Sign up to get email alerts when something new happens for Invasive Aspergillosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-08-16FDA Approved: VORICONAZOLE — Supplemental Application (Xellia Pharmaceuticals USA LLC)
FDA approved a supplemental application for Voriconazole by Xellia Pharmaceuticals USA LLC.
-
FDA approval · 2022-07-28FDA Approved: POSACONAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for posaconazole delayed-release (POSACONAZOLE DELAYED-RELEASE) from Chartwell RX, LLC, updating its…
-
FDA approval · 2022-06-13FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Voriconazole from Zydus Lifesciences Limited, updating the approval for this generic antifun…
-
FDA approval · 2022-05-25FDA Approved: POSACONAZOLE — Original Application (Par Health USA, LLC)
FDA approved the original application for posaconazole (generic) by Par Health USA, LLC, marking the availability of a generic posaconazole …
-
FDA approval · 2022-05-09FDA Approved: VORICONAZOLE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' original application for a generic voriconazole product, enabling marketing of a generic antifung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-02-17FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) submitted by Astellas Pharma US, expanding the approval throu…
-
FDA approval · 2022-02-17FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) filed by Astellas Pharma US, expanding its approved use.
-
FDA approval · 2021-12-14FDA Approved: AMPHOTERICIN B — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' original application for Amphotericin B, confirming a generic version of the antifungal. The…
-
FDA approval · 2021-12-09FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) submitted by Astellas Pharma US, Inc.
-
EMA withdrawal · 2021-08-20EMA Expired: Caspofungin Accord (caspofungin acetate) — Accord Healthcare S.L.U.
EU assessment indicates Caspofungin Accord has expired status and is no longer active on the market.
-
FDA approval · 2021-05-18FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Cresemba (isavuconazonium sulfate) filed by Astellas Pharma US, Inc. The approval adds to the ex…
-
FDA approval · 2021-04-22FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved Astellas' supplemental application for Cresemba (isavuconazonium sulfate), finalizing changes to its labeling. The action u…
-
FDA approval · 2021-02-01FDA Approved: POSACONAZOLE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved the original application for posaconazole from Lupin Pharmaceuticals, enabling generic availability of the antifungal.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels [Phase 4]
Phase 4 trial evaluating CYP2C19 genotype-specific dosing with therapeutic drug monitoring to achieve therapeutic voriconazole levels in inv…
-
FDA approval · 2020-09-16FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved Merck's supplemental application for NOXAFIL (posaconazole), updating the product labeling with new indications/usage detai…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis [Phase 2]
Phase 2 clinical trial update for Amphotericin B cholesteryl sulfate complex for injection (ABCD) in invasive candidiasis and invasive asper…
-
CLINICAL_TRIALS research · 2019-02-18Clinical Trial Update: Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients
A completed clinical trial evaluating whether a combined pharmacogenetic score influences trough voriconazole concentrations in patients wit…
-
FDA approval · 2018-11-30FDA Approved: VORICONAZOLE — Original Application (Slate Run Pharmaceuticals)
FDA approved voriconazole under an original application for Slate Run Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Exhaled Breath Analysis in the Early Detection of Aspergillosis
A completed clinical trial evaluating exhaled breath analysis for early detection of invasive aspergillosis.
-
FDA approval · 2018-03-13FDA Approved: CANCIDAS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approves a supplemental application for Cancidas (caspofungin acetate) to update labeling and/or expand its indications, as part of Merc…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Study of FK463 for the Treatment of Invasive Aspergillosis [Phase 2]
Phase 2 clinical trial update for FK463 in the treatment of invasive aspergillosis has been completed.
-
CLINICAL_TRIALS withdrawal · 2017-11-01Clinical Trial Update: Drug/Drug Interactions With F901318 [Phase 1]
A Phase 1 trial assessing drug interactions with F901318 in invasive aspergillosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-01Clinical Trial Update: Pharmacokinetics of IV Formulation [Phase 1]
Phase 1 pharmacokinetics study of an intravenous formulation from F2G Biotech GmbH for invasive aspergillosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects [Phase 1]
Phase 1 study assessing multiple ascending oral doses of F901318 in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration [NA]
The trial compared concentrations of voriconazole in blood and bronchoalveolar lavage fluid after inhaled versus oral administration in inva…